- Sputnik International, 1920
Russia
The latest news and stories from Russia. Stay tuned for updates and breaking news on defense, politics, economy and more.

RDIF: Russia Ready to Provide India With One-Shot Sputnik Vaccine for Adolescents

© Sputnik / Vladimir Zivojinovic / Go to the mediabankAn ampoule containing the Gam-Covid-Vak (Sputnik V) vaccine during vaccination against COVID-19 with the Russian drug Sputnik V at a vaccination point deployed in the building of the Belgrade Expo Center.
An ampoule containing the Gam-Covid-Vak (Sputnik V) vaccine during vaccination against COVID-19 with the Russian drug Sputnik V at a vaccination point deployed in the building of the Belgrade Expo Center. - Sputnik International, 1920, 06.12.2021
Subscribe
International
India
Africa
MOSCOW, (Sputnik) - Russia is ready to supply its single-component COVID-19 vaccine Sputnik Light and the Sputnik M vaccine for adolescents to India, who has proved to be a valuable partner in the fight against COVID-19, Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) said on Monday.
"Russia and India have joined forces since the beginning of the pandemic, with this strategic partnership including production of [the] Sputnik V and Sputnik Light vaccines. A number of agreements with partners in India have helped [the] RDIF to significantly increase our production capabilities. We are ready to offer the Sputnik Light vaccine and the Sputnik M vaccine for adolescents to support strong herd immunity in India and continue saving millions of lives", Dmitriev said.
New Delhi is already using the Russian vaccine Sputnik V, which in April 2021 became the first foreign vaccine approved for use in India.
According to the RDIF, the one-shot Sputnik Light vaccine has 70% efficacy against infection from the Delta variant of coronavirus in the first three months after standalone vaccination, with this rate rising to 83% when used as a booster shot.
The RDIF has also provided India's regulator with documents for the registration of Sputnik M, a vaccine for adolescents aged 12-17, registered by Russia's Health Ministry on 24 November 2021. If approved by Indian regulators, Sputnik M could become the first registered vaccine for adolescents in the country.
Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала